mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.7 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.7 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |